Continuum Advisory, LLC Jazz Pharmaceuticals PLC Transaction History
Continuum Advisory, LLC
- $760 Million
- Q4 2024
A detailed history of Continuum Advisory, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Continuum Advisory, LLC holds 58 shares of JAZZ stock, worth $7,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58
Previous 61
4.92%
Holding current value
$7,937
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
544Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$841 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$826 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$346 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$303 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$279 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.58B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...